GENBGenerate Biomedicines, Inc.vs its industry peers
A metric-by-metric comparison of Generate Biomedicines, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GENB본 종목 | $2.2B#7 | — | 4.7x#6 | — | — | — | — | 0.0%#2 | — | — | — | — |
| SUPN | $2.4B#1 | — | 2.4x#3 | 3.4x#3 | 8.6%#3 | -152.2%#9 | -8.7%#2 | -3.7%#3 | -5.0%#2 | — | -9.2%#7 | — |
| NKTR | $2.4B#2 | — | 2.6x#4 | 42.6x#5 | -43.9%#7 | -37.8%#7 | -253.7%#5 | -18.2%#5 | -14.0%#3 | — | 17.1%#5 | — |
| SLS | $2.3B#3 | — | 16.4x#10 | — | -100.0%#8 | 13.0%#2 | — | -19.5%#7 | — | — | 597.5%#1 | — |
| OCUL | $2.2B#4 | — | 4.3x#5 | 42.7x#6 | -18.5%#6 | -37.4%#6 | -519.8%#7 | -51.1%#9 | — | — | -20.6%#9 | — |
| PVLA | $2.2B#6 | — | 10.0x#9 | 50.6x#7 | 65.3%#2 | -139.3%#8 | -90.2%#4 | -19.2%#6 | — | — | 154.8%#2 | — |
| PBH | $2.2B#5 | 12.8x#1 | 1.1x#1 | 2.0x#2 | -4.3%#5 | -11.3%#5 | 28.4%#1 | 9.9%#1 | 5.9%#1 | 4#1 | -28.5%#10 | — |
| TRVI | $2.1B#8 | — | 6.6x#7 | — | — | 10.7%#4 | — | -13.3%#4 | — | — | 75.4%#4 | — |
| SRPT | $2.1B#9 | — | 1.4x#2 | 1.1x#1 | 4.3%#4 | -403.3%#10 | -37.5%#3 | -46.7%#8 | -73.0%#4 | — | 6.9%#6 | — |
| BHVN | $2.1B#10 | — | 171.2x#11 | — | — | 12.7%#3 | — | -6045.0%#11 | — | — | -10.7%#8 | — |
| NUVB | $2.1B#11 | — | 8.2x#8 | 32.9x#4 | 699.0%#1 | 64.0%#1 | -338.7%#6 | -80.6%#10 | -87.4%#5 | — | 86.8%#3 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice